About Us
We are a diverse group of creative innovators and advocates. We are committed to the development and use of biomedical interventions to address global health concerns.
Who we are
The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns, for which investment incentives are limited.
The institute works through collaborating partners and organizations, coordinating and driving the full spectrum of biopharmaceutical development activities, including pre-clinical development, full clinical development (from phase 1 through to and including phase 3), and global regulatory interactions.
What we do
The institute focuses on programs aimed at reducing the burden of TB, malaria, diarrheal diseases, and maternal, newborn, and child illnesses worldwide.
As an affiliate of the Bill & Melinda Gates Foundation, the institute’s programs are focused on disease and health areas of primary focus at the foundation. The interventions under study and development are derived from sources both within and external to the foundation.
Gates MRI Leadership Team
-
Emilio A. Emini, Ph.D., FCPP, FAAM Chief Executive Officer
-
Lee Bansil, Ph.D. Head of Global Communications
-
Michael Dunne, M.D., FIDSA Chief Medical Officer, Head of Development
-
Harish Kaushal, MBA, CPA Head of Finance
-
Manfred Lauchart, Ph.D. Head of Program & Portfolio Management
-
Liisa Nogelo, J.D. Lead Counsel
-
Carol O’Brien Head of Human Resources
-
Dakshina Reddy, MSc Head of Global Regulatory Strategy and Operations
-
Jared A. Silverman, Ph.D. Head of Translational Discovery
-
Piper Trelstad, Ph.D. Head of Chemistry, Manufacturing, and Controls
-
Claire M. Wagner, M.D., M.B.A. Head of Corporate Strategy
-
Debra Weiss, RN, MSN Chief Operating Officer
Work with Us
We are a diverse group of passionate change-makers, creative fixers and relentless advocates. We are committed to saving lives by improving the pace and predictability of translational medicine in global health.
